Literature DB >> 11944817

New paradigms in drug design and discovery.

Nouri Neamati1, Joseph J Barchi.   

Abstract

The new millennium has ushered in an era of science that will revolutionize a great majority of our daily activities. That revolution is being experienced by a growing number of the population who are pushing the average life expectancy closer to the 80-year mark. The primary reason for this increase is the changes we have made in the last 2-3 decades both in how we live our lives as well as how we treat our maladies when they arise. The advent of new techniques in diagnostics and surgery have allowed many to survive debilitating illnesses when their chances would have been slim only a few years ago. In addition, several new therapeutic agents have been developed in the latter part of the 20th century that have improved our quality of life and increased our overall survival time. New medicines to treat cardiovascular, degenerative, infectious, and neoplastic diseases are rapidly being discovered in an effort to further lengthen our lifetimes. The processes used by academic and industrial scientist to discover new drugs has recently experienced a true renaissance with many new and exciting techniques being developed in only the past 5-10 years. In this review, we will attempt to outline these latest protocols that chemists and biomedical scientist are currently employing to rapidly bring new drugs to the clinic.

Entities:  

Mesh:

Year:  2002        PMID: 11944817     DOI: 10.2174/1568026023394227

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  5 in total

1.  Structural basis for complementary and alternative medicine: Phytochemical interaction with non-structural protein 2 protease-a reverse engineering strategy.

Authors:  G Koushik Kumar; G Prasanna; T Marimuthu; N T Saraswathi
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

2.  Stabilization of anionic and neutral forms of a fluorophoric ligand at the active site of human carbonic anhydrase I.

Authors:  Sumathra Manokaran; Jayati Banerjee; Sanku Mallik; D K Srivastava
Journal:  Biochim Biophys Acta       Date:  2010-07-08

3.  Short and sweet: evolution of a small glycopeptide from a bladder disorder to an anticancer lead.

Authors:  Joseph J Barchi; Piotr Kaczmarek
Journal:  Mol Interv       Date:  2009-02

4.  Novel opportunities for thymidylate metabolism as a therapeutic target.

Authors:  Peter M Wilson; William Fazzone; Melissa J LaBonte; Jinxia Deng; Nouri Neamati; Robert D Ladner
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

5.  Anticancer Pyrroloquinazoline LBL1 Targets Nuclear Lamins.

Authors:  Bingbing X Li; Jingjin Chen; Bo Chao; Larry L David; Xiangshu Xiao
Journal:  ACS Chem Biol       Date:  2018-04-19       Impact factor: 5.100

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.